New hydrogel aims to stop radiation burns in breast cancer patients

NCT ID NCT05079763

Recruiting now Prevention Sponsor: University of the Philippines Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a hydrogel made from bacterial cellulose and coconut oil monolaurin to prevent severe skin reactions in Filipino women with breast cancer undergoing radiation therapy. About 54 participants will apply either the hydrogel or a placebo cream daily. The goal is to see if the hydrogel reduces the chance of high-grade skin burns, which can disrupt treatment and lower quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bacterial cellulose-monolaurin hydrogel
What this could lead to: If it works, this could offer a simple, affordable way to prevent severe skin burns during radiation therapy, improving quality of life and treatment adherence.
What could go wrong: This is a small pilot study with only 54 participants, so results may not apply to everyone. The hydrogel is compared to a placebo cream, and it may not be more effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RADIATION DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast adenocarcinoma breast neoplasm radiodermatitis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RADIATION DERMATITIS

Contacts and locations

Locations

Philippine General Hospital
RECRUITING

Manila, 1000, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.